[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hyperion Defi Inc (HYPD)

Hyperion Defi Inc (HYPD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Hyperion Defi Inc 3090 Nowitzki Way Suite 300 Dallas TX 75219 USA

https://hyperiondefi.com Employees: 9 P: 833-393-6684

Sector:

Finance

Description:

Hyperion DeFi, Inc. is the first U.S. publicly listed company building a long-term strategic treasury of HYPE. The Company provides investors with streamlined access to the Hyperliquid ecosystem, one of the fastest growing, highest revenue-generating blockchains in the world. Shareholders benefit from compounding exposure to HYPE, both from its native staking yield and additional revenues generated from its unique on-chain utility. Hyperion DeFi is also developing its proprietary Optejet User Filled Device that is designed to work with a variety of topical ophthalmic liquids, including artificial tears and lens rewetting products. The Optejet is especially useful in chronic front-of-the-eye diseases due to its ease of use, enhanced safety and tolerability, and potential for superior compliance versus standard eye drops. Together, these benefits may result in higher treatment compliance and better outcomes for patients and providers.

Key Statistics

Overview:

Market Capitalization, $K 41,230
Enterprise Value, $K 42,590
Shares Outstanding, K 15,158
Float, K 14,021
% Float 92.50%
Short Interest, K 1,532
Short Float 10.11%
Days to Cover 5.22
Short Volume Ratio 0.61
% of Insider Shareholders 7.50%
% of Institutional Shareholders 25.84%

Financials:

Annual Sales, $ 810 K
Annual Net Income, $ -45,310 K
Last Quarter Sales, $ 240 K
Last Quarter Net Income, $ 8,840 K
EBIT, $ -34,960 K
EBITDA, $ -34,000 K

Growth:

1-Year Return -59.34%
3-Year Return -98.14%
5-Year Return -99.17%
5-Year Revenue Growth -59.50%
5-Year Earnings Growth 87.50%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.92 on 08/12/26
Next Earnings Date 11/12/26
Earnings Per Share ttm -11.03
EPS Growth vs. Prev Qtr 212.20%
EPS Growth vs. Prev Year 136.80%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-80 on 02/03/25

HYPD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 1.67
Price/Earnings to Growth N/A
Return-on-Equity % -13.93%
Return-on-Assets % -11.60%
Profit Margin % -5,593.83%
Debt/Equity 0.12
Price/Sales 52.76
Price/Cash Flow N/A
Price/Book 0.55
Book Value/Share 5.12
Interest Coverage -28.04
60-Month Beta 2.53
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.